Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate Cancer-Reference-Cited by-同舟云学术

Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate Cancer

Published:2019-07 Issue:4 Volume:2 Page:456-463
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Martini Alberto,Gandaglia Giorgio,Karnes R. Jeffrey,Zaffuto Emanuele,Bianchi Marco,Gontero Paolo,Chlosta Piotr,Gratzke Christian,Graefen Markus,Tilki Derya,Cucchiara Vito,Mirone Vincenzo,Kneitz Burkhard,Sanchez Salas Rafael,Van Der Poel Henk,Tombal Bertrand,Spahn Martin,Joniau Thomas Steven,Montorsi Francesco,Briganti Alberto

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference21 articles.

1. International variation in prostate cancer incidence and mortality rates;Center;Eur Urol,2012

2. High-risk prostate cancer in the United States, 1990–2007;Cooperberg;World J Urol,2008

3. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent;Mottet;Eur Urol,2017

4. Clinically localized prostate cancer: AUA/ASTRO/SUO guideline;Sanda,2017

5. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines). Prostate cancer. https://www.nccn.org/professionals/physician_gls/f_guidelines.asp.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patients;Prostate Cancer and Prostatic Diseases;2023-07-14

3. Magnetic Resonance Imaging–based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification;European Urology Oncology;2022-10

4. Focal therapy for prostate cancer: what is really needed to move from investigational to valid therapeutic alternative?—a narrative review;Annals of Translational Medicine;2022-07

5. Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups;European Urology;2022-02